Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company imports and distributes veterinary medicines at wholesale.
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| 570 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | nmf | |
| 1,211 | 2,694 | 2,810 | 2,502 | 3,690 | 4,193 | 4,865 | 9,955 | +35.1% | |
| TOTAL ASSETS | 1,781 | 2,694 | 2,810 | 2,502 | 3,690 | 4,193 | 4,865 | 9,955 | +27.9% |
| Total Current Liabilities | 174 | 361 | 406 | 234 | 441 | 661 | 145 | 1,532 | +36.5% |
| Employee benefits | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Non-Current Liabilities | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | |
| TOTAL LIABILITIES | 174 | 373 | 406 | 234 | 441 | 661 | 145 | 1,532 | +36.5% |
| Total Equity | 1,607 | 2,321 | 2,405 | 2,269 | 3,250 | 3,532 | 4,720 | 8,423 | +26.7% |
| Share issue | 0 | 0 | 323 | 421 | 726 | 0 | 0 | 0 | +50.0% |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||||||
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Equivalents | 300 | 856 | 668 | 393 | 842 | 416 | 1,332 | 2,233 | +33.2% |
| Net Debt | 300 | 856 | 668 | 393 | 842 | 416 | 1,332 | 2,233 | +33.2% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →